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Testicular germ cell tumours (TGCT) cluster in families, but responsible genes remain unidentified. The association between testicular
microlithiasis (TM) and testicular carcinoma in situ (CIS) suggests that TM may be a TC risk factor. We report testicular ultrasound
findings in men with familial TGCT (FTGCT) and their unaffected relatives. A total of 81 men (48 affected and 33 unaffected) from 31
families with X2 TC cases underwent testicular ultrasound. Testicular microlithiasis was defined as either ‘classic’ (X5 microliths) or
‘limited’ (o5 microliths). Statistical analyses used Fisher’s exact test and permutation testing. Testicular microlithiasis was more
frequent in the contralateral testicles of men with a history of TGCT (affected men) than in unaffected men (48 vs 24%, P¼0.04).
The association appeared stronger for classic TM (21 vs 9%) than for limited TM (27 vs 15%). Testicular microlithiases were bilateral
in six out of seven (87%) unaffected men. Among affected men, TM was not associated with histology, age at diagnosis or cancer
treatment. Of the 31 families, 10 accounted for a majority (61%) of the TM cases identified (P¼0.11). Testicular microlithiasis was
more prevalent among FTGCT family members than described previously in the general population, and was more common among
FTGCT cases vs unaffected blood relatives. Testicular microlithiasis appeared to cluster in certain families. These findings suggest both
a familial predisposition to TM and an association between TM and FTGCT. If proven, this could be clinically important to men in
FTGCT families, and may be useful in identifying specific genes involved in FTGCT.
British Journal of Cancer (2008) 99, 1748–1753. doi:10.1038/sj.bjc.6604704 www.bjcancer.com
Published online 7 October 2008
& 2008 Cancer Research UK
Keywords: testicular microlithiasis; germ cell tumour; familial predisposition; genetic susceptibility; ultrasound; testicular cancer
                                                     
Testicular germ cell tumours (TGCT) account for only 1% of
malignancies in males, but constitute the most common cancer
diagnosis among men aged 20–35 years (Edwards et al, 2005). A
familial predisposition has been well documented: sons of men
with TGCT consistently display a 4- to 6-fold increased risk of
germ cell tumour compared with the general population, whereas
brothers of affected siblings have an 8- to 10-fold increased risk
(Dong and Hemminki, 2001; Hemminki and Li, 2004). However,
specific susceptibility genes that predispose to testicular cancer
have not yet been identified. Although an autosomal-recessive
model provided the best data fit in the two segregation analyses
performed to date (Nicholson and Harland, 1995; Heimdal et al,
1997), patterns of affection in multiple-case families are compa-
tible with autosomal-dominant, autosomal-recessive and X-linked
modes of inheritance, suggesting considerable genetic hetero-
geneity. Linkage analyses have revealed several potential genomic
regions of interest, including 2p23, 3p12, 3q26, 12p13–q21,
18q21–q23 and Xq27 (Rapley et al, 2000; Crockford et al, 2006),
and a specific deletion in the Y chromosome has also been
identified as conferring an increased risk of both sporadic and
familial testicular cancers in a small percentage of men (Nathanson
et al, 2005). Overall, the preponderance of data suggest that no
single major locus can account for the majority of the familial
aggregation of TGCT, but rather that multiple susceptibility loci
with weak effects appear to be involved (Crockford et al, 2006).
Although the specific aetiology of TGCT is not known, several
additional risk factors have been described, including cryptorchid
testes and contralateral testicular cancer (Garner et al, 2005).
Skaakebeck has postulated the existence of a testicular dysgenesis
syndrome, a constellation of findings including urogenital
abnormalities, subfertility, testicular carcinoma in situ and, most
importantly, TGCT. He proposed that this syndrome stems from
abnormal gonadal development during embryogenesis and foetal
life (Skakkebaek et al, 2001). Testicular microlithiasis (TM), often
seen in association with carcinoma in situ (Holm et al, 2003), may
be an additional manifestation of this disorder.
Testicular microlithiasis is characterised by the presence of
calcium deposits within the seminiferous tubules. On ultrasound,
these appear as 1–3mm echogenic foci within the parenchyma of
the testis. Prevalence estimates for TM in the general population
range from 0.6 to 9% (Miller and Sidhu, 2002). The pathophysio-
logy of these lesions is not well understood, but they are proposed
to be caused by the degeneration of the seminiferous tubules
(Dagash and Mackinnon, 2007). A number of medical conditions
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shave been associated with TM, including cryptorchidism, varico-
cele, infertility and testicular torsion (Thomas et al, 2000; Zastrow
et al, 2005). Importantly, numerous cross-sectional studies have
shown an association between TM and testicular malignancy; in
those studies, 8–54% of men with TM had concomitant TGCT
(Ganem et al, 1999; Bach et al, 2001; Otite et al, 2001; Lam et al,
2007; Parenti et al, 2007). Although TM itself is not considered to
be a problem requiring treatment, it is generally felt to be a marker
of disease within the testes, and thus follow-up is often
recommended.
One study (Coffey et al, 2007) has examined TM in the familial
setting. Testicular germ cell tumour patients with and without a
family history of TGCT, one unaffected male relative of each case
and a group of healthy male controls underwent ultrasound
examination. This study found a higher prevalence of TM among
TGCT cases than controls, and a higher than expected prevalence
of TM among male relatives of TGCT cases. This suggests a
common genetic predisposition for TM and TGCT. In addition,
TM could represent a biomarker of increased TGCT risk. In the
context of familial disease, this could be particularly helpful in
identifying individuals within a TGCT family who were at the
highest risk of developing TGCT themselves.
Thorough evaluation of men with familial TGCT and their
unaffected relatives may help to further define the familial
testicular cancer syndrome phenotype, and might permit stratify-
ing the population at familial risk into more homogenous, discrete
clinical categories with similar genetic aetiologies, thereby
improving the statistical power of gene discovery efforts. The
National Cancer Institute’s Clinical Genetics Branch (CGB) is
conducting a multidisciplinary aetiologic study of familial
testicular cancer aimed at ascertaining and studying families with
TGCT. The study objectives are to (1) characterise the clinical
phenotype of familial TGCT (Mai et al, 2007); (2) determine the
underlying genetic mechanism(s) for susceptibility to TGCT in
families (Rapley et al, 2000; Nathanson et al, 2005; Crockford et al,
2006; Coffey et al, 2007; Mueller et al, 2007); (3) evaluate
psychosocial and behavioural issues resulting from being a
member of a family at increased risk of TGCT (Peters et al,
2006, 2008) and (4) create a repository of annotated biospecimens
to permit translational research investigations. In this analysis, we
present the results of testicular ultrasound (TUS) examinations
performed during a comprehensive clinical evaluation in a subset
of families enrolled on the CGB FTGCT study.
MATERIALS AND METHODS
Families with two or more cases of documented GCT in blood
relatives (at least one of which was testicular in origin) or a single
family member with bilateral testicular cancer were eligible for the
FTGCT study. An eligible family was defined as having X2
objectively confirmed testicular or extragonadal GCTs. First-
degree relatives of a case who were X12 years and spouses of a
case who had children participating were invited to enroll in the
study. In addition, non-first-degree blood relatives who provided a
genetic link between two cases, and blood relatives with cancer
other than GCT were invited to participate.
Participants completed detailed family history, medical history,
risk factor and psychosocial/behavioural questionnaires, and were
asked to provide a research blood sample. For families in which
there were two or more affected males, the affected individuals,
their spouses and first-degree relatives were invited to travel to the
National Institutes of Health (NIH) Clinical Center for a thorough
diagnostic and research evaluation, including a detailed physician
history and physical examination, laboratory testing, semen
analysis (males aged X18 years with at least one remaining
testicle), ultrasound imaging of the testes or ovaries and computed
tomography or ultrasound of the kidneys. All participants also
attended a genetic counselling and education session. This study
has been reviewed and approved by the NCI Institutional Review
Board (NCI Protocol 02-C-0178), and all participants provided
written informed consent.
Ultrasound studies were performed at the NIH Clinical Center
Diagnostic Radiology Department between January 2003 and
November 2005 on one of two machines: the Acuson Sequoia
512 with a 14MHz probe or the Phillips HDI 5000 SonoCT with a
12MHz probe. All ultrasound examinations were reviewed by a
single radiologist (AP). We compared specific ultrasonographic
findings between the affected and unaffected individuals, and
analysed the data for associations between TM and specific
histological findings, as well as pertinent medical and surgical
history. We also investigated the possibility of familial TM
clustering by analysing the prevalence of TM in participating
families. We defined testicular microcalcification as either ‘classic’
TM (X5 microliths) or ‘limited’ TM (o5 microliths), as the latter
has also been associated with an increased risk of TC (Dagash and
Mackinnon, 2007). Statistical analyses were performed using SAS
(version 9.13). P-values for prevalence rates were calculated using
Fisher’s exact test. We assessed clustering of microlithiasis within
families using a permutation test to account for the sparse
numbers of affected men within families and men at risk,
respectively. The permutation test randomly shuffled family
indicators across subjects and testes indicators across men,
respectively, and used the Pearson w
2 as a measure of departure
from homogeneity. P-values were computed from 10000 random
shuffles.
RESULTS
We have enrolled 506 members (including 140 cases) of 99
families. This report focuses on the TUS examinations performed
on 48 affected males and 33 unaffected male blood relatives from
31 multiple-case testicular cancer families who elected to come to
NIH. Of these 31 families, 14 had two affected brothers, 6 consisted
of affected father–son pairs, three contained two affected cousins
and 8 had more than two affected family members (see Table 1).
All unaffected men were first-degree relatives of cases (affected
father¼10, affected son¼8, affected brother¼11 and affected
father and brother¼4). Cases had unilateral ultrasound performed
on their remaining testicle, whereas unaffected family members
had both testes examined, with two exceptions: one affected male
had a pineal germ cell tumour, and therefore underwent bilateral
TUS, and one unaffected male had a previous unilateral
orchiectomy to treat cryptorchidism in the context of his family
history of TGCT. Furthermore, one male with bilateral testicular
cancer who had a partial orchiectomy at the time of his second TC
diagnosis is included.
The mean age of study participants was 39 years. The mean age
at TC diagnosis was 31.5 years. One incident case of TGCT has
been detected during 5 years of prospective study follow-up
(see below for additional details). Four patients had focal testicular
lesions for which further workup was recommended. On repeat
examination, three were thought to be intratesticular cysts. One
patient with a 3-mm hypoechoic density was followed with
periodic ultrasounds for 2 years, without change; no further
evaluation was performed.
The prevalence of urogenital abnormalities among study
participants is shown in Table 2. No statistically significant
differences were noted in the prevalence of hydrocele or varicocele.
Epididymal cysts were more common in unaffected men (61 vs
40%, P¼0.06). Of the 20 unaffected men with epididymal cysts,
65% had unilateral cysts and 35% had bilateral findings. Overall,
epididymal cysts were seen in 41% (46 out of 113) of testes imaged.
Testicular microlithiasis (classic plus limited) occurred more
frequently in the contralateral testes of cases than in unaffected
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smen (48 vs 24%, P¼0.04). Among the unaffected men with
calcifications, the TMs were bilateral in six out of seven (87%).
Figure 1A shows a representative normal TUS and an ultrasound of
a male with extensive microlithiasis is shown in Figure 1B.
Table 3 lists additional factors that are potentially associated
with TM. Five out of six men who reported infertility at the time of
ultrasound examination had TM. As expected, cryptorchidism was
more frequent among cases than among unaffected men (12 vs
3%); however, the presence of TM did not correlate with history of
cryptorchidism in the full cohort of men studied. The rate of
previous inguinal hernia was similar among cases and unaffecteds
(26 vs 18%), and was not correlated with TM. Similarly, no
associations were noted between TM and history of infection
(orchitis or epididymitis), testicular injury or specific cancer
treatments. The incidence of TM did neither vary by age at
ultrasound nor by age at diagnosis among men with a history of
testicular cancer (data not shown). The prevalence of TM among
affected males did not differ by TC histology.
In this study, 8 out of 31 (26%) families had X3 family members
with a history of TGCT and 23 out of 31 had two cases. Testicular
microlithiasis was more common among families with two affected
Table 1 Family relationships and the number of affected and unaffected








1 Siblings 0 2
2 42 affected family members 1 1
3 42 affected family members 2 1
4 Father/son 1 1
5 42 affected family members 2 1
6 Siblings 2 1
7 Siblings 2 1
8 Cousins (mixed maternal/paternal) 2 1
9 Siblings 2 1
10 Father/son 2 0
11 Cousins (maternal) 2 2
12 Siblings 1 0
13 42 affected family members 2 2
14 42 affected family members 2 3
15 Father/son 2 2
16 Father/son 1 2
17 Siblings 1 0
18 Siblings 2 1
19 Cousins (paternal) 1 1
20 Siblings 1 0
21 Siblings 1 1
22 42 affected family members 2 1
23 Siblings 1 2
24 42 affected family members 1 2
25 Siblings 2 2
26 Father/son 2 0
27 42 affected family members 2 1
28 Father/son 2 0
29 Siblings 1 0
30 Siblings 2 1
31 Siblings 1 1
Table 2 Prevalence of ultrasound findings among affected and








Varicocele 5/33 (15%) 10/48 (21%) 0.57
(5–32) (10–35)
Hydrocele 4/33 (12%) 6/48 (13%) 1.00
(3–28) (5–25)
Epididymal cyst 20/33 (61%) 19/48 (40%) 0.06
(42–77) (26–55)
Microcalcifications 8/33 (24%) 23/48 (48%) 0.04
(11–42) (33–63)
Bold values indicate statistically significant findings. *P-value for comparison of the
degree of TM among affected vs unaffected study participants.
Figure 1 Testicular ultrasounds depicting (A) normal exam and (B)
extensive microlithiasis.
Table 3 Associations between TM and other conditions in FTC families
Condition TM No TM
Infertility (n¼6)
w 5/6 1/6
Inguinal hernia (n¼18) 8/18 10/18
Cryptorchidism (n¼7) 3/7 4/7
Orchitis/epididymitis (n¼5) 3/5 2/5
STD (n¼9) 5/9 4/9
Testicular injury (n¼7) 2/7 5/7
Treatment
a
History of chemotherapy (n¼18) 10/18 8/18
History of radiation therapy (n¼21) 9/21 12/21
Histology
a
Seminoma (n¼23) 10/23 13/23
Non-seminoma (n¼23) 11/23 12/23
Embryonal carcinoma 3/6 3/6
Mixed GCT 5/11 6/11
Malignant teratoma 3/5 2/5
Yolk sac/endodermal sinus tumor 0/1 1/1
wP¼0.06.
aAmong affected men only (n¼46; two patients had histology listed in the
pathology report as germinoma, NOS).
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sfamily members than in those with multiple affected family
members (65 vs 35%), but this result was not statistically
significant.
We also looked for evidence of family clustering of micro-
lithiasis. In 27 out of 31 families included in this study, ultrasound
exams were performed on X2 family members (total of 76
participants); in the remaining four families only one family
member was examined. In 12 out of 27 families (44%), there were
no cases of TM (31 family members screened); 5 out of 27 (19%)
families showed TM in o50% (5 out of 16 persons) of family
members screened, and the remaining 10 out of 27 (37%) families
had TM in X50% (19 out of 49 persons) of family members
screened. These latter 10 families accounted for 61% of TM cases
identified in this study. The permutation test P-value approached
statistical significance (P¼0.11), giving some evidence for familial
clustering.
During 5 years of study follow-up, one incident case of TGCT
has been diagnosed. This patient had bilateral classic TM at the
time of his study ultrasound in November 2005, and periodic
follow-up ultrasonography was recommended. A repeat ultrasound
in September 2007 showed stable findings. The patient noticed
a testicular lump on self-examination in January 2008, which led
to a repeat ultrasound and subsequent diagnosis of TGCT.
Retrospective review of his previous imaging studies revealed no
evidence of testicular mass. It can be noted that this patient is one
of four brothers; two of his brothers had a previous diagnosis of
unilateral testicular cancer (one had microlithiasis in his
contralateral testicle at the time of his NIH evaluation and the
other did not) and one had bilateral testicular cancer, all before
enrolling in the study. The family pedigree is shown in Figure 2.
DISCUSSION
We found a striking 48% prevalence of TM among men with a
history of TGCT, and a higher than expected prevalence (24%) in
their unaffected male family members. In contrast, studies in the
general population have shown much lower rates of TM, with
prevalence estimates ranging from 0.6 to 9% (Peterson et al, 2001;
Miller and Sidhu, 2002; Serter et al, 2006). In affected men, we
found no association between TM and the type of treatment or
TGCT histology. In addition, our data indicate that TM may cluster
in certain families. These findings raise the possibility that TM
may be an inherited condition that predisposes to testicular cancer
among men in FTGCT kindred.
It is also notable that the one incident cancer case in this study
occurred in a male from a family with both microlithiasis and a
rather remarkable family history, with four affected brothers, one
of whom had bilateral disease. To our knowledge, this is the first
report of an incident TGCT occurring during prospective follow-
up of a multiple-case family. It has been recently suggested that all
men with bilateral TGCT share a hereditary predisposition
(Harland et al, 2007); our findings lend additional credence to
this hypothesis. Thus, the combination of a significant family
history and the finding of TM on ultrasound may identify a
population of men that warrant close follow-up for the develop-
ment of TGCT.
These data support an association between TM and risk of
FTGCT. In studies of symptomatic men who underwent ultrasound
evaluation, the relative risk of TGCT in men found to have
microlithiasis, as compared with those without the condition,
ranged from 21.6 to 36.5 (Cast et al, 2000; Ringdahl et al, 2004). We
observed both a high prevalence of contralateral TM in men with a
history of unilateral TGCT and a greater than expected prevalence
of TM in unaffected male relatives.
Another study has examined the association between TM and
TGCT in the familial context. Coffey et al recently reported the
results of an analysis that included TGCT cases with and without a
family history of TGCT, male family members and normal male
controls. They found a greater prevalence of TM among cases than
among controls (43.9 vs 17.8%) and noted a similarly high
prevalence of TM among family members of cases with a family
history of TGCT (45.5%). The prevalence rates seen in that study
were remarkably similar to those presented here, and substantially
higher than those reported in the general population (Peterson
et al, 2001; Miller and Sidhu, 2002; Serter et al, 2006). Our findings
provide further evidence of an association between TM and TGCT,
specifically among individuals in FTGCT families. If confirmed,
these data could have important implications for screening in
these high-risk families by identifying a subset of family members
who might be at particularly elevated TGCT risk.
In addition, this finding may be important in the context of
efforts aimed at identifying susceptibility genes for testicular
cancer. By designating at-risk family members with TM as
‘affected’ in linkage analyses, it may be possible to significantly
increase the statistical power of gene-finding studies, which are
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Figure 2 Pedigree of a family in which multiple members have testicular cancer and microlithiasis.
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scurrently constrained, in significant part, by the limited number of
affected men in multiple-case families.
Alternative explanations for the high prevalence of TM among
affected men in our study include a shared association with other
known TGCT risk factors, and late effects of cancer-related
chemotherapy and/or radiation therapy. Previous studies have
suggested that TM is more frequent among men with infertility
and those with cryptorchidism (Thomas et al, 2000; Zastrow et al,
2005), both of which are established TGCT risk factors. In our
study, only six men reported infertility, all of whom had TGCT and
all but one had TM. As this was a retrospective analysis, we cannot
determine whether men reporting infertility had this condition
before their diagnosis of TGCT or whether it was treatment-
related. Only seven men in our study had a history of
cryptorchidism; three of whom also had TM. Given the small
numbers in our study, it is impossible to rule out a contribution of
these factors to our finding of a high prevalence of TM. In
reviewing treatment history, neither chemotherapy nor radiation
therapy was associated with an increased risk of TM in our cases.
In addition, the high prevalence of TM among unaffected men
makes a treatment effect unlikely.
Lastly, our data suggest that TM may cluster in certain families.
In our study, less than half of the families accounted for a majority
of the cases of TM, whereas another large subset of families had no
TM in any family members. Coffey et al noted a higher degree of
concordance for TM among TGCT cases and matched relative
pairs than was expected by chance (Coffey et al, 2007). This study
supports and, in fact, strengthens this observation, as we were able
to examine multiple individuals in many of the families we studied.
Taken together, these results suggest the presence of a genetic
susceptibility to TM, which may also confer an increased risk of
TGCT.
Although provocative, the findings in our study are limited by
several factors. The small sample size and cross-sectional study
design preclude drawing directional or causal conclusions. The
study population is a convenience sample of volunteers; upon
enrollment in the study, families were asked about their will-
ingness to travel to the NIH Clinical Center for an in-person
evaluation. Those included in the current analysis may not be truly
representative of the entire population of FTGCT families. Finally,
we did not have a non-familial control population, and therefore
relied upon the literature for estimates of TM prevalence in the
general population. However, this unique population of men with a
familial predisposition to testicular cancer has not been extensively
studied, and thus our findings contribute significantly to the
understanding of familial testicular cancer. These novel, although
exploratory, observations will serve as the basis for larger, more
carefully designed studies that might prove definitive.
A particular strength of this study is that all participants
underwent a comprehensive clinical evaluation by a genetics
specialty team, and systematically provided detailed medical and
family history information. In addition, all ultrasound films were
read by a single radiologist for consistency, and meticulous
attempts were made to obtain comparison and/or follow-up
studies on patients with abnormalities discovered. Furthermore,
we were able to study multiple affected and unaffected men in
our families, thus strengthening the observation that TM
appears to cluster in particular families. We are currently in the
process of bringing additional family members to the Clinical
Center for ultrasound screening, to further investigate the
association between TGCT and TM, and to evaluate the hypothesis
that TM may be a useful marker of risk in men from FTGCT
kindreds.
This study is among the first to examine TUS findings among
men with FTGCT and also the first to report an incident TGCT in
an at-risk family member during prospective follow-up. Our
finding of an unusually high prevalence of TM among men with
familial TGCT and their unaffected family members is in keeping
with that previously reported by Coffey et al. Our study further
suggests that TM clusters in certain families, a finding that we are
hoping to confirm by imaging additional members of our FTGCT
families. We propose that there may be a genetic predisposition to
TM, which is on the causal pathway to TGCT. If this can be proven,
we will be a significant step closer to identifying the specific genes
that confer susceptibility to TGCTs.
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